Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports
Open Access
- 28 August 2013
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Infectious Disease
- Vol. 1 (5), 155-165
- https://doi.org/10.1177/2049936113501816
Abstract
Over the past year, three articles have appeared in the New England Journal of Medicine describing conflicting findings about azithromycin and cardiac safety, particular azithromycin-induced QTc interval prolongation and torsade de pointes. The FDA wants healthcare providers to consider azithromycin-induced fatal cardiac arrhythmias for patients already at risk for cardiac death and other potentially arrhythmogenic cardiovascular conditions. In a systematic review of case reports we sought to determine factors that link to azithromycin-induced/associated QTc interval prolongation and torsade de pointes. We found 12 cases: seven female and five male. Of the nine adults with reported azithromycin doses, concurrent QTc interval measurement, and without congenital long QT syndrome, we found no significant relationship between dose and QTc interval duration. Additional risk factors were female sex, older age, heart disease, QTc interval prolonging drugs and metabolic inhibitors, hypokalemia, and bradycardia. All 12 subjects had at least two additional risk factors. Elderly women with heart disease appear to be at particularly risk for drug-related QTc interval prolongation and torsade de pointes.Keywords
This publication has 42 references indexed in Scilit:
- Sudden Cardiac Arrest in a Patient on Chronic Methadone After the Addition of AzithromycinThe American Journal of the Medical Sciences, 2013
- Methadone, QTc interval prolongation and torsade de pointes: Case reports offer the best understanding of this problemTherapeutic Advances in Psychopharmacology, 2013
- Azithromycin and the Risk of Cardiovascular DeathNew England Journal of Medicine, 2012
- Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancyExpert Opinion on Drug Metabolism & Toxicology, 2011
- Antimicrobials and the Risk of Torsades de PointesDrug Safety, 2010
- The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidanceBritish Journal of Pharmacology, 2010
- No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic‐AV blockBritish Journal of Pharmacology, 2006
- Torsades de pointes induced by antibioticsEuropean Journal of Internal Medicine, 2006
- Erythromycin block of the HERG K+ channel: Accessibility to F656 and Y652Biochemical and Biophysical Research Communications, 2006
- QT Prolongation with Antimicrobial AgentsDrugs, 2004